Skip to main content

Tarsus Pharmaceuticals, Inc S-3ASR, filed Oct 13, 2026

Tarsus Pharmaceuticals, Inc. (TARS)

Tarsus Pharmaceuticals, Inc. registered up to 2,232,144 shares of common stock for resale by selling stockholders, comprising 2,098,519 shares and 133,625 shares issuable upon exercise of pre-funded warrants. The company will receive no proceeds from share sales. AI summary

S-3ASR 2026-10-13
View Original
Added on October 16, 2026